XENE
Xenon Pharmaceuticals Inc.
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $0 | −25.3% |
| Operating income | −$465M | — |
| Net income | −$429M | — |
| EPS | −$4.70 | — |
| Free cash flow | −$357M | — |
Xenon Pharmaceuticals Inc.
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $0 | −25.3% |
| Operating income | −$465M | — |
| Net income | −$429M | — |
| EPS | −$4.70 | — |
| Free cash flow | −$357M | — |